Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fear | 15 | 2024 | 249 | 5.170 |
Why?
|
| Extinction, Psychological | 15 | 2024 | 90 | 4.640 |
Why?
|
| Prefrontal Cortex | 6 | 2019 | 137 | 2.830 |
Why?
|
| Limbic System | 6 | 2016 | 25 | 2.550 |
Why?
|
| Action Potentials | 14 | 2019 | 231 | 2.240 |
Why?
|
| Neurons | 14 | 2019 | 1175 | 2.170 |
Why?
|
| Synapses | 6 | 2019 | 180 | 1.970 |
Why?
|
| Hippocampus | 8 | 2024 | 561 | 1.870 |
Why?
|
| Neuronal Plasticity | 3 | 2019 | 103 | 1.700 |
Why?
|
| Receptors, Metabotropic Glutamate | 4 | 2015 | 28 | 1.600 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2024 | 43 | 1.500 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2024 | 1618 | 1.300 |
Why?
|
| Cerebral Cortex | 5 | 2015 | 290 | 1.200 |
Why?
|
| Conditioning, Classical | 4 | 2019 | 61 | 1.150 |
Why?
|
| Thalamus | 5 | 2015 | 30 | 1.120 |
Why?
|
| Rats | 20 | 2024 | 3483 | 1.100 |
Why?
|
| Glutamic Acid | 5 | 2015 | 128 | 1.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2023 | 389 | 0.930 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2023 | 37 | 0.910 |
Why?
|
| Animals | 33 | 2024 | 15081 | 0.900 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2023 | 53 | 0.890 |
Why?
|
| Interneurons | 5 | 2004 | 56 | 0.800 |
Why?
|
| Association Learning | 2 | 2019 | 30 | 0.780 |
Why?
|
| Benzimidazoles | 2 | 2023 | 36 | 0.760 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2019 | 137 | 0.700 |
Why?
|
| Patch-Clamp Techniques | 8 | 2016 | 223 | 0.600 |
Why?
|
| Astrocytes | 6 | 2012 | 255 | 0.560 |
Why?
|
| Male | 17 | 2024 | 20025 | 0.550 |
Why?
|
| Receptor, EphB2 | 1 | 2015 | 5 | 0.530 |
Why?
|
| Tetrazoles | 1 | 2015 | 49 | 0.520 |
Why?
|
| Pyramidal Cells | 3 | 2008 | 63 | 0.510 |
Why?
|
| Amygdala | 1 | 2015 | 114 | 0.490 |
Why?
|
| Somatosensory Cortex | 2 | 2007 | 24 | 0.490 |
Why?
|
| Memory | 3 | 2010 | 170 | 0.480 |
Why?
|
| Excitatory Postsynaptic Potentials | 3 | 2015 | 79 | 0.460 |
Why?
|
| Neocortex | 4 | 2000 | 27 | 0.430 |
Why?
|
| Receptors, Muscarinic | 1 | 2012 | 18 | 0.420 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1015 | 0.400 |
Why?
|
| KCNQ Potassium Channels | 1 | 2010 | 4 | 0.380 |
Why?
|
| Presynaptic Terminals | 2 | 2004 | 53 | 0.370 |
Why?
|
| RNA, Small Interfering | 2 | 2024 | 409 | 0.330 |
Why?
|
| Gene Expression | 3 | 2008 | 674 | 0.320 |
Why?
|
| Acoustic Stimulation | 3 | 2017 | 66 | 0.310 |
Why?
|
| alpha-Synuclein | 1 | 2008 | 52 | 0.310 |
Why?
|
| Cues | 2 | 2019 | 55 | 0.290 |
Why?
|
| Organ Culture Techniques | 3 | 2012 | 103 | 0.290 |
Why?
|
| Neural Pathways | 2 | 2019 | 124 | 0.280 |
Why?
|
| Calcium | 5 | 1999 | 480 | 0.280 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2005 | 4 | 0.270 |
Why?
|
| Receptors, Purinergic P1 | 2 | 2015 | 7 | 0.260 |
Why?
|
| RNA, Messenger | 4 | 2017 | 1207 | 0.250 |
Why?
|
| Electrophysiology | 4 | 2008 | 136 | 0.250 |
Why?
|
| Receptors, GABA-B | 1 | 2004 | 11 | 0.250 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2024 | 34 | 0.240 |
Why?
|
| Mitochondria | 1 | 2008 | 487 | 0.240 |
Why?
|
| Corticosterone | 1 | 2024 | 77 | 0.240 |
Why?
|
| Neural Inhibition | 2 | 2001 | 48 | 0.240 |
Why?
|
| Excitatory Amino Acid Antagonists | 4 | 2013 | 99 | 0.230 |
Why?
|
| Stress, Psychological | 2 | 2023 | 583 | 0.230 |
Why?
|
| Pituitary-Adrenal System | 1 | 2023 | 39 | 0.230 |
Why?
|
| Faculty | 1 | 2023 | 94 | 0.220 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1999 | 9 | 0.210 |
Why?
|
| Electric Stimulation | 3 | 2015 | 184 | 0.200 |
Why?
|
| Analysis of Variance | 2 | 2017 | 550 | 0.200 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2007 | 48 | 0.200 |
Why?
|
| Mice | 7 | 2015 | 5913 | 0.190 |
Why?
|
| Receptors, Neurotransmitter | 2 | 1997 | 21 | 0.180 |
Why?
|
| Intracellular Membranes | 2 | 1996 | 38 | 0.170 |
Why?
|
| Cytokines | 1 | 2023 | 602 | 0.170 |
Why?
|
| Reward | 1 | 2019 | 79 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 208 | 0.160 |
Why?
|
| Receptors, Nicotinic | 1 | 1999 | 106 | 0.160 |
Why?
|
| Inflammation | 1 | 2023 | 618 | 0.160 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 1371 | 0.150 |
Why?
|
| Cholinergic Agents | 2 | 2012 | 8 | 0.150 |
Why?
|
| Exploratory Behavior | 1 | 2017 | 75 | 0.140 |
Why?
|
| Maze Learning | 1 | 2017 | 105 | 0.140 |
Why?
|
| omega-Conotoxins | 1 | 1996 | 4 | 0.140 |
Why?
|
| Avoidance Learning | 1 | 2017 | 62 | 0.140 |
Why?
|
| Biphenyl Compounds | 1 | 2015 | 53 | 0.130 |
Why?
|
| Mental Recall | 1 | 2015 | 78 | 0.130 |
Why?
|
| Random Allocation | 1 | 2015 | 139 | 0.130 |
Why?
|
| Models, Animal | 1 | 2015 | 134 | 0.130 |
Why?
|
| Microelectrodes | 1 | 2015 | 23 | 0.130 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 32 | 0.130 |
Why?
|
| Students | 2 | 2023 | 519 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2015 | 149 | 0.120 |
Why?
|
| Female | 3 | 2023 | 20969 | 0.120 |
Why?
|
| Evoked Potentials | 2 | 2005 | 87 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2015 | 86 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 220 | 0.120 |
Why?
|
| Time Factors | 2 | 2017 | 1742 | 0.120 |
Why?
|
| AIDS Dementia Complex | 1 | 2014 | 102 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 893 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 218 | 0.110 |
Why?
|
| Adenosine Triphosphate | 2 | 2008 | 196 | 0.100 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 51 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2012 | 73 | 0.100 |
Why?
|
| Adenosine | 2 | 2005 | 59 | 0.100 |
Why?
|
| Transfection | 2 | 2012 | 523 | 0.100 |
Why?
|
| Anthracenes | 1 | 2010 | 13 | 0.090 |
Why?
|
| Potassium Channel Blockers | 1 | 2010 | 33 | 0.090 |
Why?
|
| Aminopyridines | 1 | 2010 | 15 | 0.090 |
Why?
|
| Rats, Wistar | 3 | 2000 | 233 | 0.090 |
Why?
|
| Analgesics | 1 | 2010 | 54 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2015 | 400 | 0.090 |
Why?
|
| Receptors, Glutamate | 3 | 2000 | 27 | 0.090 |
Why?
|
| Humans | 7 | 2023 | 37093 | 0.080 |
Why?
|
| Cyclooxygenase 1 | 1 | 2008 | 11 | 0.080 |
Why?
|
| Electroshock | 1 | 2008 | 17 | 0.080 |
Why?
|
| Rotenone | 1 | 2008 | 19 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 91 | 0.080 |
Why?
|
| Insecticides | 1 | 2008 | 51 | 0.080 |
Why?
|
| Norepinephrine | 1 | 2008 | 110 | 0.080 |
Why?
|
| Receptors, Presynaptic | 1 | 2007 | 4 | 0.070 |
Why?
|
| Xanthenes | 1 | 2007 | 11 | 0.070 |
Why?
|
| Cyclopropanes | 1 | 2007 | 40 | 0.070 |
Why?
|
| Anticonvulsants | 1 | 2007 | 34 | 0.070 |
Why?
|
| Glycine | 1 | 2007 | 47 | 0.070 |
Why?
|
| Amino Acids | 1 | 2007 | 145 | 0.070 |
Why?
|
| Osmolar Concentration | 2 | 1996 | 58 | 0.070 |
Why?
|
| Ubiquinone | 1 | 2006 | 22 | 0.070 |
Why?
|
| Vitamins | 1 | 2006 | 94 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1039 | 0.060 |
Why?
|
| Baclofen | 1 | 2004 | 8 | 0.060 |
Why?
|
| Mice, Inbred ICR | 2 | 2001 | 40 | 0.060 |
Why?
|
| Dopamine | 1 | 2006 | 245 | 0.060 |
Why?
|
| Iron | 1 | 2006 | 225 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 55 | 0.060 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 245 | 0.060 |
Why?
|
| GABA Antagonists | 2 | 2000 | 29 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2012 | 1518 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 180 | 0.050 |
Why?
|
| Parvalbumins | 1 | 2001 | 16 | 0.050 |
Why?
|
| Dendrites | 1 | 2001 | 55 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 623 | 0.050 |
Why?
|
| Reaction Time | 1 | 2001 | 143 | 0.050 |
Why?
|
| Lysine | 1 | 2001 | 113 | 0.050 |
Why?
|
| Axons | 1 | 2001 | 108 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 64 | 0.050 |
Why?
|
| Nerve Net | 1 | 2000 | 76 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2008 | 1908 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2000 | 146 | 0.040 |
Why?
|
| Tetrodotoxin | 1 | 1999 | 22 | 0.040 |
Why?
|
| Cholecystokinin | 1 | 1999 | 16 | 0.040 |
Why?
|
| Acetylcholine | 1 | 1999 | 73 | 0.040 |
Why?
|
| DNA Primers | 1 | 1998 | 286 | 0.040 |
Why?
|
| Apoptosis | 1 | 2006 | 1398 | 0.040 |
Why?
|
| Cell Communication | 1 | 1998 | 97 | 0.040 |
Why?
|
| 4-Aminopyridine | 1 | 1996 | 7 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1996 | 56 | 0.030 |
Why?
|
| Receptors, Purinergic | 1 | 1995 | 4 | 0.030 |
Why?
|
| Cycloleucine | 1 | 1995 | 2 | 0.030 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 9 | 0.030 |
Why?
|
| School Admission Criteria | 1 | 2015 | 9 | 0.030 |
Why?
|
| Kainic Acid | 1 | 1995 | 48 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1995 | 70 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 29 | 0.030 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 57 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 175 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2008 | 343 | 0.030 |
Why?
|
| Peptides | 1 | 1996 | 320 | 0.030 |
Why?
|
| Brain Tissue Transplantation | 1 | 2012 | 3 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 85 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2015 | 1378 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 418 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 439 | 0.020 |
Why?
|
| HIV-1 | 1 | 2014 | 706 | 0.020 |
Why?
|
| Thionucleotides | 1 | 2008 | 9 | 0.020 |
Why?
|
| Propranolol | 1 | 2008 | 18 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 52 | 0.020 |
Why?
|
| Conditioning, Operant | 1 | 2008 | 73 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 141 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 122 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2008 | 131 | 0.020 |
Why?
|
| Coenzymes | 1 | 2006 | 13 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2006 | 13 | 0.020 |
Why?
|
| Siderophores | 1 | 2006 | 9 | 0.020 |
Why?
|
| Deferoxamine | 1 | 2006 | 19 | 0.020 |
Why?
|
| Metallothionein | 1 | 2006 | 22 | 0.020 |
Why?
|
| Dopamine Agents | 1 | 2006 | 25 | 0.020 |
Why?
|
| Melanins | 1 | 2006 | 36 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 314 | 0.020 |
Why?
|
| Anxiety | 1 | 2012 | 754 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 140 | 0.020 |
Why?
|
| Glutathione | 1 | 2006 | 179 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4268 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2006 | 178 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 617 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 461 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2006 | 339 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 933 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 1354 | 0.010 |
Why?
|
| GABA Agonists | 1 | 2000 | 21 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1609 | 0.010 |
Why?
|
| Receptors, AMPA | 1 | 2000 | 56 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2000 | 11 | 0.010 |
Why?
|
| Seizures | 1 | 2000 | 68 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 10129 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 97 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2000 | 223 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 11712 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 360 | 0.010 |
Why?
|
| Aging | 1 | 2000 | 664 | 0.010 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 1994 | 14 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1994 | 34 | 0.010 |
Why?
|
| Brain | 1 | 1994 | 1346 | 0.000 |
Why?
|